Senate lawmakers pass a bill to declassify U.S. intelligence information regarding coronavirus and its origins
Two vaccines made by China’s Sinopharm appear safe and effective against COVID-19, according to a study published in a medical journal.
Scientists had been waiting for more details about the two vaccines, even though they already are being used in many countries, and one recently won the backing of the World Health Organization for emergency use.
The report, published online in the Journal of the American Medical Association, concluded the two vaccines are about 73% and 78% effective, as Sinopharm has previously claimed.
Researchers from Sinopharm and its local partners in the Middle East say the trial involved around 40,380 participants with the company s two vaccines one developed by the Wuhan Institute of Biological Products and the other by the Beijing Institute of Biological Products and a placebo. The trial was carried out in four countries Bahrain, the Uni
Researchers from Sinopharm and its local partners in the Middle East say the trial involved around 40,380 participants with the company s two vaccines one developed by the Wuhan Institute of Biological Products and the other by the Beijing Institute of Biological Products and a placebo. The trial was carried out in four countries Bahrain, the United Arab Emirates, Egypt and Jordan. However, the study provided data for just Bahrain and the UAE. There s nothing very surprising. It s consistent with what they have claimed previously, but it does not completely eliminate the doubts about Sinopharm, said Jin Dong-yan, a medical professor at the University of Hong Kong who was not involved with the study.
Two vaccines made by China s Sinopharm appear safe and effective against COVID-19, according to a study published in a medical journal. Scientists had been waiting for more details about the two vaccines, even though they already are being used in many countries, and one recently won the backing of the World Health Organisation for emergency use. The report, published online in the Journal of the American Medical Association, concluded the two vaccines are about 73 per cent and 78 per cent effective, as Sinopharm has previously claimed. Researchers from Sinopharm and its local partners in the Middle East say the trial involved around 40,380 participants with the company s two vaccines one developed by the Wuhan Institute of Biological Products and the other by the Beijing Institute of Biological Products and a placebo.
Expanding Covid-19 vaccine production is top priority: Chinese Consul General Xuhang
Photo: Juidin Bernarrd/KT
The diplomat praises the UAE’s emergence as a manufacturing and logistics hub for Sinopharm vaccine
Expanding the production of Chinese vaccines is the top priority and the UAE as a manufacturing and logistics hub would push the goal to immunise more people globally, the Chinese Consul General in Dubai Li Xuhang told
Khaleej Times in an exclusive interview on Thursday (May 27). China-UAE cooperation in producing vaccines in the UAE will undoubtedly provide more powerful means to carry out international anti-epidemic outreach. We look forward to the smooth implementation of this programme, he said.